Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Workers' Comp
Article
Workers' Compensation Pharmacy Legislative and Regulatory End of Year Recap
New regulations, proposed legislation, and notable judicial developments made 2024 a significant year for workers' compensation pharmacy programs.
Workers' Comp
Podcast
Managing the Seismic Shift from Inpatient to Outpatient Physical Medicine Services
Workers' Comp
Article
Ask The Pharmacist: Preventing Tetanus in Workers’ Compensation
What is tetanus and how can it be prevented? Tetanus is a serious infectious disease that can result from workplace injuries.
Workers' Comp
Case Study
Field Case Manager Delivers Early Full Duty Release
Workers' Comp
Case Study
AuditPro Resolved Overcharged Medical Services
Workers' Comp
Case Study